Fanconi syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Fnaconi syndrome is characterized by freely losses of water, HCO3-, Na+ and K+, all classes of aminoacids, uric acid, LMW nutrients, and glucose in line with evidence of proximal renal tubular acidosis(P-RTA). It has been mentioned that one or two of the above substances can have normal renal excertion and the disease still be called (however incomplete) Fanconi syndrome. | Fnaconi syndrome is characterized by freely losses of water, HCO3-, Na+ and K+, all classes of [[Amino acid|aminoacids]], [[uric acid]], LMW nutrients, and [[glucose]] in line with evidence of proximal [[renal tubular acidosis]](P-RTA). It has been mentioned that one or two of the above substances can have normal renal excertion and the disease still be called (however incomplete) Fanconi syndrome. | ||
==Differentiating "Fanconi syndrome" from other Diseases== | ==Differentiating "Fanconi syndrome" from other Diseases== | ||
*The differential diagnosis(DDx) of the syndrome is mainly done on the basis of clinical and laboratory findings. Hence the disease must be differentiated with all of the other conditions which partly present its characteristics and clinical findings (and so cannot be called Fanconi syndrome yet) or just have some limited features in common. The most important DDxs are: | *The differential diagnosis(DDx) of the syndrome is mainly done on the basis of clinical and laboratory findings. Hence the disease must be differentiated with all of the other conditions which partly present its characteristics and clinical findings (and so cannot be called Fanconi syndrome yet) or just have some limited features in common. The most important DDxs are: | ||
** Glomerular defects | ** [[Glomerular]] defects | ||
** [[Diuretic]] use | ** [[Diuretic]] use | ||
** [[Nephrotic syndrome]] | ** [[Nephrotic syndrome]] | ||
Line 16: | Line 16: | ||
** Distal [[RTA]] | ** Distal [[RTA]] | ||
===Preferred Table=== | ===Preferred Table<ref name="pmid22990302">{{cite journal| author=Viganò C, Amoruso C, Barretta F, Minnici G, Albisetti W, Syrèn ML et al.| title=Renal phosphate handling in Gitelman syndrome--the results of a case-control study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 1 | pages= 65-70 | pmid=22990302 | doi=10.1007/s00467-012-2297-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22990302 }}</ref>=== | ||
{| | {| | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="9" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
Line 27: | Line 27: | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
! colspan=" | ! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dehydration | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dehydration | ||
Line 36: | Line 36: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Growth | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Growth | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Proteinuria | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Proteinuria | ||
!Aminoaciduria | |||
!Serum Phosphate | !Serum Phosphate | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum Na+ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum [Na<sup>+</sup>] | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum K+ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum [K<sup>+</sup>] | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Anion Gap | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Anion Gap | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum PH | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum PH | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine PH | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine PH | ||
! | !Urine [Ca<sup>2+</sup>] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Fanconi Syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>-/+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| '''<big>+</big>''' | |||
| '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | <small>5.5</small>'''<big>↓</big>''' | |||
| '''<big>↓/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Proximal RTA | |||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
|'''<big>-</big>''' | |||
!N | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | <small>5.5</small>'''<big>↓</big>''' | |||
!N | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Distal RTA | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
|'''<big>-</big>''' | |||
!N | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" |<small>5.5</small><big>'''↑'''</big> | |||
| <big>'''↑'''</big> | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |RTA Type IV | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 68: | Line 106: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
|'''<big>-</big>''' | |||
!N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓ ↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | <big>'''↑ ↑'''</big> | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | <small>5.5</small>'''<big>↓</big>''' | |||
| '''<big>↓/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |- | ||
| style="background: # | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Nephrotic Syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
|'''<big>-</big>''' | |||
!N | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" |'''N''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
! style="background: #F5F5F5; padding: 5px;" |N | |||
!N | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Gitelman syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>+</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>''' | |||
|'''<big>-</big>''' | |||
| '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↓/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" | '''<big>↑/</big>N''' | |||
| style="background: #F5F5F5; padding: 5px;" | <big>'''↑'''</big> | |||
| style="background: #F5F5F5; padding: 5px;" |<small>5.5</small><big>'''↑'''</big> | |||
| '''<big>↓</big>''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
|Bartter's syndrome | |||
| '''<big>+</big>''' | |||
| | |||
| | |||
| '''<big>↓</big>''' | |||
|'''<big>-</big>''' | |||
| '''<big>-/+</big>''' | |||
|'''<big>-</big>''' | |||
|'''<big>-</big>''' | |||
| | |||
| '''<big>↓/</big>N''' | |||
| '''<big>↓/</big>N''' | |||
| '''<big>↑/</big>N''' | |||
| <big>'''↑'''</big> | |||
|<small>5.5</small><big>'''↑'''</big> | |||
| <big>'''↑'''</big> | |||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|} | |} | ||
Revision as of 15:49, 18 June 2018
Fanconi syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fanconi syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Fanconi syndrome differential diagnosis |
Risk calculators and risk factors for Fanconi syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Fnaconi syndrome is characterized by freely losses of water, HCO3-, Na+ and K+, all classes of aminoacids, uric acid, LMW nutrients, and glucose in line with evidence of proximal renal tubular acidosis(P-RTA). It has been mentioned that one or two of the above substances can have normal renal excertion and the disease still be called (however incomplete) Fanconi syndrome.
Differentiating "Fanconi syndrome" from other Diseases
- The differential diagnosis(DDx) of the syndrome is mainly done on the basis of clinical and laboratory findings. Hence the disease must be differentiated with all of the other conditions which partly present its characteristics and clinical findings (and so cannot be called Fanconi syndrome yet) or just have some limited features in common. The most important DDxs are:
- Glomerular defects
- Diuretic use
- Nephrotic syndrome
- Gitelman syndrome
- Bartter's syndrome
- Proximal RTA
- Distal RTA
Preferred Table[1]
Diseases | Clinical manifestations | Para-clinical findings | Additional findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||
Lab Findings | ||||||||||||||||
Dehydration | Lethargy | Musculoskeletal pain | Blood Pressure | Edema | Growth | Proteinuria | Aminoaciduria | Serum Phosphate | Serum [Na+] | Serum [K+] | Anion Gap | Serum PH | Urine PH | Urine [Ca2+] | ||
Fanconi Syndrome | + | + | + | -/+ | ↓ | + | + | ↓ | ↓/N | ↓/N | N | ↓ | 5.5↓ | ↓/N | ||
Proximal RTA | - | - | - | - | N | N | ↓/N | N | ↓ | 5.5↓ | N | |||||
Distal RTA | - | - | - | N | N | ↓/N | N | ↓ | 5.5↑ | ↑ | ||||||
RTA Type IV | - | - | N | ↓ ↓ | ↑ ↑ | N | ↓ | 5.5↓ | ↓/N | |||||||
Nephrotic Syndrome | + | + | + | - | N | ↓/N | N | ↓/N | N | N | N | |||||
Gitelman syndrome | + | ↓ | - | - | - | - | ↓ | ↓/N | ↓/N | ↑/N | ↑ | 5.5↑ | ↓ | |||
Bartter's syndrome | + | ↓ | - | -/+ | - | - | ↓/N | ↓/N | ↑/N | ↑ | 5.5↑ | ↑ | ||||
References
- ↑ Viganò C, Amoruso C, Barretta F, Minnici G, Albisetti W, Syrèn ML; et al. (2013). "Renal phosphate handling in Gitelman syndrome--the results of a case-control study". Pediatr Nephrol. 28 (1): 65–70. doi:10.1007/s00467-012-2297-3. PMID 22990302.